P1488: COMBINING ALK2 INHIBITION WITH A MODIFIED ACTIVIN RECEPTOR IIA LIGAND TRAP PROVIDED ADDITIVE BENEFITS IN RESOLVING ANEMIA IN A MOUSE MODEL OF ANEMIA OF INFLAMMATION

• Chia-Yu Wang,
• Emiliano Melgar-Bermudez,
• Diana Welch,
• Claire Tseng,
• Ffolliott Fisher,
• Samuel Cadena,
• Lorena Lerner,
• Jasbir Seehra,
• Jenn Lachey

Affiliations

Chia-Yu Wang

1 Keros Therapeutics, Lexington, MA, United States

Emiliano Melgar-Bermudez

1 Keros Therapeutics, Lexington, MA, United States

Diana Welch

1 Keros Therapeutics, Lexington, MA, United States

Claire Tseng

1 Keros Therapeutics, Lexington, MA, United States

Ffolliott Fisher

1 Keros Therapeutics, Lexington, MA, United States

Samuel Cadena

1 Keros Therapeutics, Lexington, MA, United States

Lorena Lerner

1 Keros Therapeutics, Lexington, MA, United States

Jasbir Seehra

1 Keros Therapeutics, Lexington, MA, United States

Jenn Lachey

1 Keros Therapeutics, Lexington, MA, United States